User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Monotherapy or combination therapy for hospitalized patients with community-acquired pneumonia: not yet the end of the story?

  • Open access
  • PDF
  • 169.87 K
  1. Lim W S, Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines, 10.1136/thorax.56.4.296
  2. Lave JR, Semin Respir Crit Care Med, 20, 189 (1999)
  3. Bodí M., Rodríguez A., Solé-Violán J., Gilavert M. C., Garnacho J., Blanquer J., Jimenez J., de la Torre M. V., Sirvent J. M., Almirall J., Doblas A., Badía J. R., García F., Mendia A., Jordá R., Bobillo F., Vallés J., Broch M. J., Carrasco N., Herranz M. A., Rello J., , Antibiotic Prescription for Community-Acquired Pneumonia in the Intensive Care Unit: Impact of Adherence to Infectious Diseases Society of America Guidelines on Survival, 10.1086/498119
  4. Laterre Pierre-Francois, Garber Gary, Levy Howard, Wunderink Richard, Kinasewitz Gary T., Sollet Jean-Pierre, Maki Dennis G., Bates Becky, Yan Sau Chi Betty, Dhainaut Jean-Francois, Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study* : , 10.1097/01.ccm.0000162381.24074.d7
  5. FRIEND J. A R, Do smoking parents seek the best advice for their asthmatic children?, 10.1136/thorax.56.1.1
  6. Mandell Lionel A., Wunderink Richard G., Anzueto Antonio, Bartlett John G., Campbell G. Douglas, Dean Nathan C., Dowell Scott F., File Thomas M., Musher Daniel M., Niederman Michael S., Torres Antonio, Whitney Cynthia G., Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults, 10.1086/511159
  7. Gleason Patrick P., Meehan Thomas P., Fine Jonathan M., Galusha Deron H., Fine Michael J., Associations Between Initial Antimicrobial Therapy and Medical Outcomes for Hospitalized Elderly Patients With Pneumonia, 10.1001/archinte.159.21.2562
  8. Waterer Grant W., Somes Grant W., Wunderink Richard G., Monotherapy May Be Suboptimal for Severe Bacteremic Pneumococcal Pneumonia, 10.1001/archinte.161.15.1837
  9. Baddour Larry M., Yu Victor L., Klugman Keith P., Feldman Charles, Ortqvist Ake, Rello Jordi, Morris Arthur J., Luna Carlos M., Snydman David R., Ko Wen Chien, Chedid M. Bernadete F., Hui David S., Andremont Antoine, Chiou Christine C. C., Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia, 10.1164/rccm.200311-1578oc
  10. Shefet Daphna, Robenshtok Eyal, Paul Mical, Leibovici Leonard, Empirical Atypical Coverage for Inpatients With Community-Acquired Pneumonia : Systematic Review of Randomized Controlled Trials, 10.1001/archinte.165.17.1992
  11. Mortensen Eric M, Restrepo Marcos I, Anzueto Antonio, Pugh Jacqueline, 10.1186/cc3934
  12. Torres A, Clin Infect Dis, 46, 1499 (2008)
  13. Petitpretz Patrick, Arvis Pierre, Marel Miroslav, Moita Joaquim, Urueta Juan, Oral Moxifloxacin vs High-Dosage Amoxicillin in the Treatment of Mild-to-Moderate, Community-Acquired, Suspected Pneumococcal Pneumonia in Adults, 10.1378/chest.119.1.185
  14. Finch R., Schurmann D., Collins O., Kubin R., McGivern J., Bobbaers H., Izquierdo J. L., Nikolaides P., Ogundare F., Raz R., Zuck P., Hoeffken G., Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment, 10.1128/aac.46.6.1746-1754.2002
  15. Portier H., Brambilla C., Garre M., Paganin F., Poubeau P., Zuck P., Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors, 10.1007/s10096-005-1347-1
  16. Metersky Mark L., Ma Allen, Houck Peter M., Bratzler Dale W., Antibiotics for Bacteremic Pneumonia, 10.1378/chest.06-1426
Bibliographic reference Laterre, Pierre-François. Monotherapy or combination therapy for hospitalized patients with community-acquired pneumonia: not yet the end of the story?. In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 46, no.10, p. 1510-1512 (2008)
Permanent URL http://hdl.handle.net/2078.1/200899